Eikon Therapeutics Inc
NASDAQ:EIKN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Seach Medical Group Ltd
TASE:SEMG
|
IL |
|
Nippon Steel Trading Corp
TSE:9810
|
JP |
Eikon Therapeutics Inc
EPS (Diluted)
Eikon Therapeutics Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Eikon Therapeutics Inc
NASDAQ:EIKN
|
EPS (Diluted)
-$6
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$2
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$6
|
CAGR 3-Years
23%
|
CAGR 5-Years
132%
|
CAGR 10-Years
-5%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$14
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$15
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$41
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
22%
|
|
Eikon Therapeutics Inc
Glance View
Eikon Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Hayward, California. The company went IPO on 2026-02-05. Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. The company tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.
See Also
What is Eikon Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-6.2
USD
Based on the financial report for Dec 31, 2025, Eikon Therapeutics Inc's EPS (Diluted) amounts to -6.2 USD.
What is Eikon Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
-37%
Over the last year, the EPS (Diluted) growth was -37%.
